CER(d18:1/18:1), the substrates of ACER3, exhibited negative correlations with SCSMs in patients with cholestasis (Fig. 1c), and ACER3 ablation specifically increased CER(d18:1/18:1) (Figs. 4 and 8). Here, CBLN1 is linked to cholestasis.